Camidanlumab (anti-CD25) is a CD25 monoclonal antibody. Camidanlumab (anti-CD25) targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab (anti-CD25) can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia.
Specification: ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB182785-SCI_10ce534a383394b538500b9b37822f67.pdf
- UPC:
- 51202407
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab182785-10mg
- CAS:
- 921618-45-3
- Product Size:
- 10mg